The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

PRESS: Glaxo Closes Plant Amid Legionnaire's Disease Fears - NYT

Wed, 12th Aug 2015 08:39

LONDON (Alliance News) - GlaxoSmithKline PLC has shut down a North Carolina plant which produces inhaled medications after it discovered the bacteria which causes Legionnaire's disease at the site, The New York Times reported.

The manufacturing plant in Zebulon was closed on Tuesday after the bacteria was found in cooling towers, the newspaper said. Legionnaire's disease is a deadly form of pneumonia and got its name after an epidemic break-out in 1976 at a Legionnaires' convention held in Philadelphia.

http://www.nytimes.com/2015/08/12/business/glaxosmithkline-plant-closes-after-legionnaires-discovery.html?_r=0

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted...

Today 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Today 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Za...

Today 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Today 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.